Comparative efficacy, tolerability and acceptability of donanemab, lecanemab, aducanumab and lithium on cognitive function in mild cognitive impairment and Alzheimer's disease: A systematic review and network meta-analysis

The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record